Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Biochim Biophys Acta. 2017 Jun 6;1866(1):80–87. doi: 10.1016/j.bbapap.2017.06.002

Fig. 4.

Fig. 4

Schematic representation of the oxygen tolerant deazaflavin/EDTA approach using the CYP102A1 (P450 BM3) holoenzyme for the selective hydroxylation of lauric acid.